Allergy and Immunology · Santa Barbara, CA
NPI
1346253390
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
215 Pesetas Ln
Santa Barbara, CA, 93110
Phone (805) 681-1761
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
1,381 services
Medicare patients, 2024
265
Average age 74
Drug cost, 2024
$1.9M
1,401 prescriptions
Company payments, 2025
$21K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Myron Liebhaber was code 95004 (test - miscellaneous), 464 times for 19 patients. In total Myron Liebhaber billed 1,381 services in 24 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 464 | 19 | $3.17 | $1,472 |
| 99213 Office E&M - Established | Office | 134 | 120 | $72.23 | $9,679 |
| 99214 Office E&M - Established | Office | 129 | 107 | $100.03 | $13K |
| 95117 Treatment - Miscellaneous | Office | 117 | 22 | $10.83 | $1,268 |
| 99204 Office E&M - New | Office | 54 | 54 | $134.90 | $7,284 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 17 | $34.22 | $582 |
| 94010 Pulmonary Function Testing | Office | 16 | 15 | $24.10 | $386 |
| 90653 Vaccine Product | Office | 15 | 15 | $81.82 | $1,227 |
| 95012 Pulmonary | Office | 13 | 13 | $17.32 | $225 |
| 99203 Office E&M - New | Office | 11 | 11 | $87.57 | $963 |
By year: 2022 $59K for 1,808 services; 2023 $67K for 2,109 services; 2024 $45K for 1,381 services.
Medicare prescription drug claims, 2024
In 2024, the drug Myron Liebhaber prescribed most often to Medicare patients was Montelukast Sodium, with 171 prescriptions and refills. In total Myron Liebhaber wrote 1,401 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 171 | 453 | 56 | $1,909 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 107 | 119 | 53 | $3,067 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 96 | 108 | 20 | $8,746 |
| Breo Ellipta Fluticasone/Vilanterol | 84 | 90 | 12 | $34K |
| Fluticasone Propionate Generic | 73 | 163 | 32 | $958 |
| Azelastine Hcl Generic | 70 | 111 | 27 | $1,547 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 67 | 87 | 16 | $8,997 |
| Prednisone Generic | 42 | 48 | 19 | $155 |
| Symbicort Budesonide/Formoterol Fumarate | 42 | 56 | Under 11 | $11K |
| Breyna Budesonide/Formoterol Fumarate | 36 | 42 | Under 11 | $4,018 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 34 | 46 | 11 | $29K |
| Spiriva Respimat Tiotropium Bromide | 30 | 44 | Under 11 | $22K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 29 | 46 | Under 11 | $8,177 |
| Azithromycin Generic | 27 | 27 | 16 | $84.32 |
| Arnuity Ellipta Fluticasone Furoate | 26 | 34 | Under 11 | $6,200 |
Brand drugs: 608 claims; generic drugs: 793 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Myron Liebhaber $21K ($21K in general payments such as food, travel and fees) from 17 companies. The largest payer was CSL Behring with $11K.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 15 | $11K |
| Pharming Healthcare, Inc. | 17 | $8,365 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $1,337 |
| GlaxoSmithKline, LLC. GSK | 21 | $341 |
| BioCryst US Sales Co., LLC | 4 | $132 |
| Ionis Pharmaceuticals, Inc. IONS | 4 | $101 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $98.57 |
| Amgen Inc. AMGN | 4 | $97.7 |
| Genzyme Corporation SNY | 4 | $80.19 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 3 | $73.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.